Digital Health Views & Analysis

Views & Analysis

Digital

GenAI and the revolution of drug development

Bryan Hill, life sciences chief technology officer at Cognizant, discusses how generative AI is revolutionising drug development in a new podcast.

Digital

Medicine doctor writing electronic medical record

Driving innovation in rare diseases: Digital health and coll...

In recognition of Rare Disease Day, Dr Kamran Iqbal, head of medical affairs and patient advocacy in global rare diseases at Chiesi UK, discussed with pharmaphorum the company’s evolving ro

Digital

Enhancing medical education through gamification and innovat...

As the demands of modern healthcare grow, new therapies are introduced at record speeds, and guidelines are quickly updated, it is key that medical education evolves to keep up.

Digital

Pharma's AI is missing the "Why”

Artificial intelligence (AI) is reshaping the pharmaceutical industry, driving advances from drug discovery and clinical trial acceleration to manufacturing optimisation and commercialisati

Digital

Chris Moore Veeva and Nicole Raleigh pharmaphorum interview

Pharma digitalisation and transformation of HCP engagement w...

Web editor Nicole Raleigh spoke with Veeva Systems’ president of Europe, Chris Moore, for a discursive dive into the life sciences

Digital

Taking the quantum leap: How life science real estate cluste...

The beauty of quantum computing is that it is poised to power groundbreaking discoveries that would dramatically alter what we, as a nation, and globally, are capable of achieving.

GenAI and the revolution of drug development

Driving innovation in rare diseases: Digital health and coll...

Enhancing medical education through gamification and innovat...

Pharma's AI is missing the "Why”

Pharma digitalisation and transformation of HCP engagement w...

Taking the quantum leap: How life science real estate cluste...

ASCO 2026: Quality of life, not just quantity, with Dr Harol...

Discover a new era of healthcare panel engagement: Grounded ...

Views & Analysis

Editor's Picks